Oct 18, 2019 / 03:30PM GMT
Operator
Good morning, and welcome to the Johnson & Johnson conference call. (Operator Instructions) This call is being recorded. If anyone has any objections, you may disconnect at this time. (Operator Instructions)
I will now like to turn the call over to Chris DelOrefice, Vice President of Investor Relations for Johnson & Johnson. Thank you. You may begin.
Chris DelOrefice - Johnson & Johnson - VP of IR
Great. Thank you, everyone, for taking the time to connect today. Joining me today is Kathy Wengel, Executive Vice President and Chief Global Supply Chain Officer; Dr. Susan Nicholson, Vice President of Women's Health in our medical safety organization; and Lynne Szczepaniak, Vice President, Regulatory Affairs, Consumer.
As you saw, we did issue a press release earlier today about our voluntary recall of 1 lot of Johnson's Baby Powder. Product quality and safety are important issues for us, and we know that they're important to you as well. While Johnson & Johnson is continuing to investigate the matter in cooperation with the FDA, we
Johnson & Johnson Investor Conference Call on Voluntary Baby Powder Lot Recall Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot